Abstract
The thymus constitutes the primary lymphoid organ for the generation of T cells. Its function is particularly susceptible to various negative influences ranging from age-related involution to atrophy as a consequence of malnutrition, infection or harmful iatrogenic influences such as chemotherapy and radiation. The loss of regular thymus function significantly increases the risk for infections and cancer because of a restricted capacity for immune surveillance. In recent years, thymus-stimulatory, thymus-regenerative, and thymus-protective strategies have been developed to enhance and repair thymus function in the elderly and in individuals undergoing hematopoietic stem cell transplantation. These strategies include the use of sex steroid ablation, the administration of growth and differentiation factors, the inhibition of p53, and the transfer of T cell progenitors to alleviate the effects of thymus dysfunction and consequent T cell deficiency.
Original language | English (US) |
---|---|
Pages (from-to) | 443-453 |
Number of pages | 11 |
Journal | Current Opinion in Pharmacology |
Volume | 10 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2010 |
Bibliographical note
Funding Information:Financial support: This work was supported by the Swiss National Science Foundation (grants 3100-68310.02 to GAH and 3100-129838 to WK) and by the National Institutes of Health (grant ROI-AI081918 to GAH and BRB; and grant P01CA067493 to BRB).